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doi:10.1016/j.ejvs.2009.01.011Abstract Objectives: To determine whether there is any evidence of a systematic reduction
in the operative risk of carotid endarterectomy (CEA) for symptomatic stenosis in recent years.
Methods: We performed a systematic review of all studies published between 2000 and 2008
inclusive that reported the risks of stroke and death for symptomatic carotid stenosis. We
compared the reported risks with our previous review of studies published prior to 2001 and
between studies that were reported by surgeons alone and studies that included neurologists
or stroke physicians as assessors/authors, with particular reference to the proportion of oper-
ative strokes to operative deaths.
Results: Of 494 studies, only 53 reported operative risks for patients with symptomatic
stenosis separately. In keeping with the findings of our previous review, the pooled
operative risk of stroke and death reported in studies published by surgeons alone
(3.9%, 95% confidence interval (CI): 3.4e4.3) was significantly lower (p< 0.001) than that
reported in studies that involved neurologists (5.6%, 95% CI: 5.1e6.2). The pooled ratio
of operative stroke:operative death was 4.0 (range: 3.6e4.5) in studies involving neurol-
ogists or stroke physicians and 2.7 (range: 2.1e3.9) in studies involving only surgeons
(pZ 0.002). We found no evidence of a reduction in published risks of death or stroke
and death due to CEA for symptomatic carotid stenosis between 1985 and 2008. Indeed,
the 1.4% (range: 1.2e1.6%) pooled operative mortality in studies published during
2001e2008 was significantly higher than that reported in ECST and NASCET (1.0%, 95%
CI: 0.9e1.1%). However, the average age of patients having CEA has continued to
increase during this period.) 1865231603; fax: þ44 (0) 1865234639.
neuro.ox.ac.uk (P.M. Rothwell).
ty for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
Risks of Carotid Endarterectomy 505Conclusions: There is no evidence of a systematic reduction over the last decade in the
published risks due to CEA for symptomatic stenosis. The lower proportion of non-fatal
operative strokes in surgeon-only studies suggests that some minor operative strokes
have been missed.
ª 2009 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights
reserved.It has been shown in large randomised trials that carotid
endarterectomy (CEA) reduces the risk of stroke in patients
with recently symptomatic 70% stenosis and is of some
benefit in selected patients with recently symptomatic 50e
69% stenosis.1e3 Benefit depends on maintaining a low
operative risk of stroke and death. Some surgeons now
operate on low-risk patients with 50e69% stenosis,
believing that improved surgical techniques make current
operative risks significantly lower than the 7% risk of stroke
and death reported in the major trials performed in the late
1980s and early 1990s.4,5 This belief is supported by more
recent reports of operative risk of stroke and death of
2e3%.5,6 However, low operative risks were also reported in
the 1980s.7,8 Moreover, there have also been significant
improvements in the medical management of carotid
disease in recent years, which might reduce the absolute
benefit of CEA even if the operative risk has fallen. Before
proposing any broadening of the indications for surgery over
and above those from the randomised trials, it is important
to establish whether there is any evidence of a systematic
reduction of surgical risk in recent years.
Assessment of the absolute risk of stroke and death
from CEA in routine clinical practice is difficult. Large
studies of data routinely collected are least likely to have
selection or publication bias.9,10 However, these studies
often only report data on operative mortality and do not
usually differentiate CEA for symptomatic stenosis from
CEA for asymptomatic stenosis. The risks of stroke and
death in published case series are very heterogeneous,
partly because of differences in how outcome was
assessed11 and partly because of differences in case
mix.7,12,13 However, if analyses of time trends are strati-
fied according to such factors, it is possible to determine
by studying published reports whether operative risks
have fallen significantly in recent years. We therefore
systematically reviewed all studies on the outcome of CEA
for symptomatic carotid stenosis published from 2001 to
2008 and compared the operative risks with those from
the ECST and NASCET1,2 and our previous review of earlier
studies.7,8,14 Most studies published before 2000 recruited
patients during the same period as the large trials, but
most studies published after 2000 recruited patients after
the trials stopped randomising patients with severe
stenosis in 1991.15,16
Methods
We updated our previous review by systematically review-
ing all published papers reporting outcome of CEA from 1
January 2001 to 31 August 2008. We re-searched 2000
again. Although our previous review covered the period upto and including 2000, there is a delay between publication
of papers and inclusion in bibliographic databases, so we
could have missed some papers published towards the end
of our previous review period.
Search strategy
The literature search for our previous review was done by
two independent researchers with a high degree of agree-
ment (>90%)14 in identification of eligible studies. The
current search for this updated review was therefore per-
formed by one researcher only (KR).
1) Studies were identified from Medline and Embase with
‘carotid endarterectomy’ as the search term. Animal
studies, studies with results of carotid surgery for non-
atherosclerotic disease and review articles with no
original data were excluded by reading the titles or the
abstract and full paper where necessary. The reviewer
then searched the resulting list of references for any
reports that might contain relevant information. These
were then pooled, and the process was repeated, using
either the abstract and/or the full report to establish
relevance (Fig. 1).
2) The bibliographies of all papers identified electronically
were also searched.
3) The six journals with the largest number of relevant
papers were searched manually for the period 2000e
2008 (Fig. 1).
Inclusion criteria
Papers published in any language were included if they
fulfilled the following criteria:
1) The numbers of combined strokes and deaths occurring
within 30 days of CEA (or a similar time period) were
reported.
2) The risks of stroke and/or death were defined, or able
to be calculated, per operation.
3) Operative risks were reported by clinical indication. As
a minimum, operative risks for symptomatic and
asymptomatic stenosis were reported separately.
4) Patients with bilateral simultaneous endarterectomy
were excluded, or data were reported separately so
that they could be excluded from the analysis.
5) Patients with synchronous endarterectomy and coro-
nary artery bypass grafting were excluded, or data
were reported separately so that they could be
excluded from the analysis.
Figure 1 Strategy and results of the literature search.
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One researcher (KR) reviewed each article and recorded the
number of operations performed, the number of patients
undergoing surgery and the number of strokes and deaths
during the operative and postoperative periods. Another
researcher (PMR) reviewed the data. All disagreements were
re-examined jointly and corrections made when necessary.
To locate duplicate reporting of the same cohort of patients,
the authorship of all papers was cross-referenced. When
duplication was thought likely, only one paper (usually the
paper reporting the larger cohort) was included. After
exclusion of duplicates or articles with inadequate data,
a final database of articles was compiled for analysis.
Analysis
ManteleHaenszel meta-analysis was used to calculate
pooled estimates of operative risk. Allowance was madefor extra-binomial variation when calculating the 95%
confidence intervals (CIs) of the pooled risk estimates17
since standard methods of calculating CIs result in arti-
ficially narrow intervals when there is heterogeneity of
risk in different studies. To study time trends of opera-
tive risk, the authors combined our results with those
from our previous review of studies published before
2000.7,8,14
The pooled analyses of operative risk of stroke and
death were stratified according to whether one or more
authors were affiliated to a department of neurology or
medicine, even if it was not explicitly stated who had
assessed the outcome. We also calculated the ratio of all
operative strokes to operative deaths (an indirect
measure of the severity of operative strokes e the
proportion of non-fatal strokes) and obtained pooled
estimates for studies including neurologist or stroke
physician authors versus studies with surgeon authors
only.
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The results of the literature search are in Fig. 1. A total of
4984 references were found by electronic search; of these,
4355 were excluded by reading the titles, since they were
clearly review articles, animal studies or reports of non-
endarterectomy carotid surgery. After a review of the
abstracts, the remaining 629 references were reduced to
434. In addition, 22 papers were found from the reference
lists of these 434 papers, and an additional 88 papers were
found by a manual search of the six journals that furnished
most papers in the electronic search for the period 2000e
2008 (Fig. 1). There were 22 papers that had been pub-
lished during 1995e2000 but had not been identified and
included in the previous review.
After excluding duplicates or articles with inadequate
data, a final database was compiled of 494 articles, pub-
lished in 2000e2008, relating to the risk of stroke and death
following CEA. Of these, 164 reported the outcome of
surgery but had no information about the indication, and
256 reported the proportion of symptomatic versus
asymptomatic patients operated upon but did not report
the operative risk separately. Of the remaining 74 studies,
53 reported data on the operative risks of stroke and death
rate following CEA for symptomatic carotid stenosis. An
additional 103 studies were included from our previous
review covering the period before 2001.
The overall pooled estimate of the operative risk of
stroke and death reported in studies published from 2001 to
2008 was 4.9% (95% CI: 4.3e5.3). However, as in the previous
review,7,8,14 the operative risk in studies published by
surgeons only (3.9%, 3.4e4.3%, 25 studies) was significantly
lower (pZ 0.002) than that in studies with some involve-
ment of neurologists or stroke physicians (5.6%, 5.1e6.2%,
21 studies). The risks in studies that involved neurologists or
stroke physicians were similar to those in the ECST and
NASCET combined (7.0%, 6.2e8.0%). There was significant
heterogeneity in the risks of stroke and death within bothFigure 2 Meta-analysis of operative death rates and combined
symptomatic patients in studies with authorship by surgeons only, p
of the heterogeneity of odds ratios across studies.23-53groups of studies (Fig. 2), but 14 of the 21 studies with
a neurologist or stroke physician had higher risks than the
3.9% pooled estimate from the surgeon-only studies (Fig. 3).
Furthermore, the pooled estimate of risk of stroke and death
in the neurologist or stroke physician studies was still higher
than that in the surgeon-only studies when the analysis was
restricted to non-trial case series (5.6%, 5.1e6.2%, 16
studies) by exclusion of data from the Wallstent,18 Ken-
tucky,19 EVA-3S,20 SPACE21 and BACASS trials.22
The overall risk of operative death in the 34 studies that
reported operative mortality separately for symptomatic
patients from 2001 to 2008 was 1.4% (95% CI: 1.2e1.6). This
operative mortality was greater than that reported in ECST
and NASCET (1.0%, 95% CI: 0.9e1.1). However, there was no
statistically significant difference in operative mortality
between surgeon-only studies (1.1%, 95% CI: 0.7e1.6, 19
studies) and studies with a neurologist or stroke physician
(1.5%, 95% CI: 1.3e1.7, 15 studies). The pooled ratio of
operative stroke to operative death was 4.0 (3.6e4.5) in
studies with neurologists or stroke physicians and 2.7 (2.1e
3.9) in studies with surgeons only (p< 0.001). The lower
proportion of non-fatal operative strokes in surgeon-only
studies suggests that some minor operative strokes were
missed.
The time trends in operative risk are detailed in Table 1
and Fig. 4. Although at first there was a significant reduc-
tion in stroke and death rates published up to 1980, there
has been no statistically significant change over the last 25
years (Fig. 4). Throughout this period, published risks from
studies with a neurologist or stroke physician have been
consistently higher than those in surgeon-only studies
(Table 1). This difference was most pronounced in the small
number of early studies.
The average age of patients operated on has gradually
increased from 60.9 years in studies prior to 1980 to 70.3
years in studies from 2000 to 2008 (p< 0.00001, Fig. 4).
However, the sex ratio has not changed significantly; 32.3%
of operations were done on women from 2000 to 2008.stroke and death rates following carotid endarterectomy in
ublished during 2001e2008. p(het) is the statistical significance
Figure 3 Meta-analysis of operative death rates and combined stroke and death rates following carotid endarterectomy in
symptomatic patients in studies with authorship including a neurologist or stroke physician, published during 2001e2008. p(het) is
the statistical significance of the heterogeneity of odds ratios across studies.18-22,48,54-69
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We attempted to review all of the published literature on
the operative risk of death and stroke due to CEA for
symptomatic stenosis. However, electronic searches inevi-
tably miss some published studies, and it was impossible to
search every journal manually. However, it is unlikely thatFigure 4 Time trends in studies of carotid endarterectomy for
operative death rates and stroke and death rates (above) and avethere was a systematic bias of inclusion of studies with
respect to reported mortality or morbidity. Complete
ascertainment of reports is vital in systematic reviews of
randomised controlled trials because ‘negative’ trials are
more likely to be published in low-profile journals and to
therefore be missed. The potential biases due to under-
ascertainment of surgical case series are likely to besymptomatic stenosis published between 1980 and 2008 for:
rage age of patients operated upon (below).
Table 1 Time trends of the risk of stroke and death and operative mortality from carotid endarterectomy in symptomatic
patients stratified by authorship for studies published during 1980e2008.
Neurologist or Physician Surgeon only
N Stroke and death (95% CI) Death (95% CI) N Stroke and death (95% CI) Death (95% CI)
Year published
Pre 1980 4 18.3 (12.2e24.4) 6 (2.1e11.2) 3 4.7 (2.4e7.0) 3.1 (0.8e5.4)
1980e1984 7 13.2 (7.6e18.8) 4.3 (0.0e8.8) 9 4.1 (2.9e5.3) 1.6 (0.9e2.3)
1985e1989 3 6.4 (4.6e8.2) 5 (1.4e1.7) 14 5.0 (4.0e6.0) 1.4 (1.1e1.7)
1990e1993 6 6.5 (5.4e7.6) 2.9 (0.3e5.5) 12 4.6 (3.6e5.6) 1.9 (1.3e2.4)
1994e2000 11 6.5 (4.3e8.7) 1.6 (1.3e2.0) 34 4.2 (3.5e4.9) 1.4 (1.2e1.6)
2001e2008 21 5.6 (5.1e6.2) 1.5 (1.3e1.7) 25 3.9 (3.4e4.3) 1.1 (0.7e1.6)
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published from 2001 to 2008 fulfilled our inclusion criteria,
the vast majority of studies being excluded simply because
the risks of CEA were not reported separately for patients
undergoing surgery for symptomatic and asymptomatic
stenosis. Since the risks of surgery for asymptomatic
stenosis are consistently lower than those for symptomatic
stenosis,7,14 combined risks would have been difficult to
interpret. These exclusions were unavoidable and were also
unlikely to have introduced substantial bias. Most impor-
tantly, the same methodology was applied in our previous
review and therefore any effects of study selection should
not have biased our assessment of time trends.
The risks of stroke and death reported were statistically
significantly heterogeneous between studies. Differences
between studies may be attributable to differences in case
mix or surgical experience, but the analysis suggests that
differences in study methodology account for some of the
heterogeneity. As in the previous review,8,14 studies with
some involvement of a neurologist or stroke physician had
risks of stroke and death higher than those in studies with
surgeons only. Potential reasons for this disparity have
already been discussed.11,70 In brief, it is likely that publi-
cation bias explains some of the difference. Surgeons with
high operative risks may not be inclined to publish results.
It is more likely that neurologists will audit operative risks if
they are high. Another explanation is diagnostic bias:
neurologists are more likely to identify minor strokes. This
latter explanation is supported by analysis of the proportion
of operative strokes that were fatal, or the ratio of non-
fatal operative stroke to operative mortality. In NASCET15
and ECST,16 this ratio was 6 and 8, respectively. It is likely
that studies with much lower ratios have missed some non-
fatal strokes. Figs. 2 and 3 show that 39% of surgeon-only
studies had ratios of 2 or less compared to only 6% of studies
with a neurologist or stroke physician. Irrespective of the
reasons, the results here support the previous recommen-
dation that a neurologist should audit the operative risk
of CEA.11
Many surgeons feel that the outcome of surgery has
improved over time because of better quality control and
better patient selection. However, although it may be
possible to show that results are improving in some centres,
there is less evidence of widespread changes. The 5.6%
overall risk of stroke or death from CEA in studies from 2001
to 2008 with some involvement of a neurologist or stroke
physician is very consistent with the operative risks reportedin ECST and NASCET,15,16 the American Heart Association
guidelines12,13,71 and the earlier review.7,8,14
Importantly, the overall pooled 1.4% risk of operative
death in studies published during 2001e2008 is statistically
significantly higher than the 1.0% risk reported in ECST and
NASCET. This difference might be explained partially by
differences in case mix, particularly the exclusion, mainly
from NASCET, of various categories of patients with a high
operative risk.15 However, the relatively high operative
mortality in published case series highlights the importance
of appropriate patient selection and fully informed consent.
In conclusion, we have found no evidence that the
operative risks of CEA for symptomatic stenosis has fallen
over the last two decades. In published case series and trials,
risks of both operative mortality and stroke and death have
remained stable, although the age of patients has progres-
sively increased. It is difficult to reliably interpret temporal
trends in published risks, given the changes in the frequency
of operations over the past 25 years and probable changes in
the types of patients undergoing surgery. However, claims
that operative risks have fallen to such levels that the results
of the ECST and NASCET no longer apply to current clinical
practice cannot be substantiated. Indeed, improvements in
best medical treatment of patients with carotid artery
disease are likely, if anything, to have reduced the absolute
benefit of CEA. It is important, therefore, that operative
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